Cardialen IncCompany Details

Get alertedif Cardialen Inc gets funded!
United States
St. Louis
Industry:Medical devices and equipment
Detailed industries:biotechnology
Company description

CardiaLen holds rights to its low-energy cardioversion technology under an exclusive global joint license from Washington University in St. Louis and Case Western Reserve University to develop and commercialize certain intellectual property developed by Professor Igor Efimov, Ph.D. This technology has the potential to provide pain-free cardioversion-defibrillation therapy for both atrial and ventricular arrhythmias, conditions where major unmet needs exist. CardiaLen will focus primarily on atrial fibrillation, a serious and growing condition worldwide, and secondarily on ventricular fibrillation. It will in strategic alliances with industry partners, as appropriate. Pain-free cardioverter-defibrillators will offer significant patient benefits but will require extensive preclinical testing, clinical trials and regulatory approval prior to entering the market. CardiaLen is jointly located in St. Louis, MO, where it maintains its headquarters and clinical affairs office, and Minneapolis-St. Paul, MN, where it conducts contract product development. MoreLess


Funding history

Create alert
Want to know when Cardialen Inc gets funded?
Key people
Brian BuetnerDirector
Robert CalcaterraDirector, Executive_Officer
Igor EfimovDirector
Eric GulveDirector, Executive Officer
Nick LannersExecutive Officer
Travis MurphyCFO
M. SheltonExecutive Officer
Paula SkjefteCEO, Director, Executive Officer
D. ThomasDirector, Executive_Officer
Warren WatsonDirector
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!